Improved outcome of extremely low birth weight infants with Tegaderm application to skin

Vineet Bhandari1, Nancy Brodsky, Rachel Porat

  • 1Division of Neonatology, Department of Pediatrics, Albert Einstein Medical Center, Philadelphia, PA, USA.

Insights

Applying semipermeable polyurethane membrane (Tegaderm) to extremely low birth weight (ELBW) infants shortly after birth reduces fluid and electrolyte disturbances. This intervention significantly improves clinical outcomes, including reduced lung disease and mortality.

Area of Science:

  • Neonatalogy
  • Pediatric Critical Care
  • Perinatal Medicine

Background:

  • Extremely low birth weight (ELBW) infants experience significant fluid and electrolyte imbalances in early life.
  • These disturbances can negatively impact clinical outcomes.

Purpose of the Study:

  • To investigate the effect of semipermeable polyurethane membrane (Tegaderm) application on fluid and electrolyte status in ELBW infants.
  • To assess the impact of Tegaderm on clinical outcomes, including mortality and respiratory disease.

Main Methods:

  • Retrospective chart review of ELBW infants (BW < 1.0 kg) before and after Tegaderm implementation.
  • Daily data collection on fluid intake, weight, serum electrolytes, and BUN/creatinine during the first week of life.
  • Comparison of clinical morbidities (IVH, NEC, PDA, sepsis, BPD) and survival rates between groups.

Main Results:

  • Tegaderm application was associated with significantly lower serum Na levels, daily fluid intake, and daily weight loss in the first week.
  • Fewer infants in the Tegaderm group developed hypernatremia (17% vs 51%) and required high fluid intake (13% vs 54%).
  • The Tegaderm group showed improved respiratory outcomes (less BPD, reduced need for supplemental oxygen) and higher survival rates (90% vs 64%).

Conclusions:

  • Semipermeable polyurethane membrane application is effective in mitigating fluid and electrolyte disturbances in ELBW infants.
  • Tegaderm significantly improves clinical outcomes, including reduced bronchopulmonary dysplasia and decreased mortality.
  • Early skin barrier management with Tegaderm is a beneficial intervention for ELBW infants.
Abstract